USP To Explore Standardized Imprint Coding For Solid Oral Dosage Forms
The United States Pharmocopeia voted to approve a resolution to explore the advisability of developing standardized imprint coding for all solid oral dosage forms at its quinquennial meeting April 16 in Washington, D.C.
You may also be interested in...
U.S. Pharmacopoeia-created MedMARx reporting system would be expanded under legislation introduced by Rep. Morella (R-Md.) Feb. 16
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials